Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is currently trading at 1,028.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Yatharth Hospital operates a network of super-speciality hospitals across Delhi NCR, Uttar Pradesh and Madhya Pradesh, providing tertiary healthcare through hospitals, advanced surgeries, oncology, robotics, transplant programmes and diagnostic capabilities. Its cluster-based model combines established facilities with recently acquired hospitals in high-density urban and underserved regional markets. Q2 FY27 revenue increased 52% year-on-year to Rs 4,314 million, while EBITDA rose 50% to Rs 1,020 million. Reported margin was 23.6%, but adjusted margin reached 28.2% excluding ramp-up losses from newer hospitals, indicating that mature facilities remain substantially more profitable than the consolidated headline suggests. New hospitals already represented 28% of Q2 revenue, compared with 11% a year earlier, while existing hospitals still delivered 24% year-on-year growth. This combination is notable because Yatharth is simultaneously scaling its footprint and compounding the performance of its established Noida, Greater Noida, Noida Extension and Jhansi-Orchha assets. Operational metrics improved meaningfully: occupancy reached 72%, ARPOB rose 11% year-on-year to Rs 35,948, and average length of stay declined to 3.33 days. The improvement reflects higher patient volumes, faster discharges and a growing speciality and payer mix, although several recently added hospitals remain below mature occupancy levels. The proposed Advent partnership could change Yatharth’s growth trajectory materially. A Rs 3,150 crore primary investment and global healthcare expertise may accelerate the company’s earlier 5,000-bed plan toward 7,000–8,000 beds within three to five years, while the promoter family remains the largest shareholder at approximately 42% after dilution.

Over the past 52 weeks, Yatharth Hospital & Trauma Care Services Ltd has traded between a low of ₹538.15 and a high of ₹1,183.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of approximately 9,473.56. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Yatharth Hospital & Trauma Care Services Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 52.15 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 9,473.56 Cr, Yatharth Hospital & Trauma Care Services Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Yatharth Hospital & Trauma Care Services Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Yatharth Hospital & Trauma Care Services Ltd is 52.15. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Yatharth reported occupancy of 72% in Q2FY27, compared with 66% in Q2FY26 and 68% in Q1FY27. The Q2FY27 calculation was based on 1,820 operational census beds, while total bed capacity was 2,555.

Yatharth reported revenue from operations of Rs 431.4 crore in Q2 FY27. This was 52% higher than Rs 283 crore in Q2 FY26 and 10% above Rs 392.7 crore in Q1 FY27.

Yatharth is targeting 7,000–8,000 beds within three to five years. Management previously showed a 5,000-bed goal over three years and describes the revised range as a 40–60% uplift with Advent.

Yatharth said newer hospitals contributed 28% of Q2 FY27 revenue, equal to Rs 120.5 crore. Their revenue-mix share was 27% in Q1 FY27 and 11% in Q2 FY26. The category includes Greater Faridabad, New Delhi Model Town, Faridabad Sec-20 and Agra.